The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

BACKGROUND: The hallmark of Type 2 diabetes (T2D) is hyperglycemia, although there are multiple other metabolic abnormalities that occur with T2D, including insulin resistance and dyslipidemia. To advance T2D prevention and develop targeted therapies for its treatment, a greater understanding of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Amit, Shiloach, Joseph, Betenbaugh, Michael J, Gallagher, Emily J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362840/
https://www.ncbi.nlm.nih.gov/pubmed/25784953
http://dx.doi.org/10.1186/s12986-015-0003-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362840/
https://www.ncbi.nlm.nih.gov/pubmed/25784953
http://dx.doi.org/10.1186/s12986-015-0003-8

Ejemplares similares